All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe

November 2009 Editor's Picks: Products from Enercon Industries and Schreiner MediPharm

November 18, 2009
By Pharmaceutical Technology Editors
Article

Equipment and Processing Report

Equipment and Processing ReportEquipment and Processing Report-11-18-2009
Volume 0
Issue 0

PharmTech's monthly newsletter, Equipment & Processing Report, reviews the Editor's Picks for the November 2009 edition from Enercon and Schreiner.

Enercon Industries
Sealer enhances productivity

The Super Seal Touch induction cap sealer from Enercon Industries (Menomonee Falls, WI) provides as much as 20% more induction-sealing power than the company’s previous devices. This increase in power is designed to boost productivity.

The unit’s redesigned cap-inspection system is integrated electrically and mechanically with the sealer to reduce setup time. In addition, the system includes recipe-management capabilities. Operators can store parameters for various products by name and perform product changeover easily. Users also can block other operators from adjusting the system.

The sealer’s touchscreen improves operator control and allows the unit to provide data about the sealing system. The touchscreen displays faults in descriptive text instead of codes and also supports several languages. The sealer also provides network connectivity, thus allowing packagers to control and monitor cap sealing data remotely from a central location.

Schreiner MediPharm
Hologram seal makes counterfeiting difficult

Schreiner MediPharm’s (Oberschleißheim, Germany) Transparent-Hologram-Seal is intended to provide reliable evidence of tampering and counterfeiting and ensure that patients receive pharmaceutical products intact. The seal is fixed to the package with a strong adhesive so that an attempt to peel it off would damage the packaging surface. In addition, the seal’s 2D single-image design and holographic effects are designed to make counterfeiting especially difficult and thus ensure the safety of packaged pharmaceuticals.

The seal is transparent so that variable data on the package such as batch information is legible and intact. The Transparent-Hologram-Seal is appropriate for small- and large-volume production. Schreiner MediPharma and its sister company Schreiner ProSecure codeveloped the seal. Schreiner ProSecure specializes in authentication, tamper-protection, and track-and-trace solutions.

Articles in this issue

Purple-Pig-2-641599-1408639116798.jpg
Pigging Can Improve Efficiency and Sustainability
Are Microreactors Practical for Large-Scale Production?
Enercon_SuperSeal-2-641618-1408639097259.jpg
November 2009 Editor's Picks: Products from Enercon Industries and Schreiner MediPharm
Recent Videos
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content

The mRNA or messenger Ribonucleic Acid white text for medical or outbreak concept 3d rendering | Image Credit: ©niphon - adobe.stock.com

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

Cheryl Barton
June 24th 2025
Article

mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Pharmacist weighing chemical | Image Credit: © Kzenon - stock.adobe.com

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

Paul L. Pluta;Nishant B. Thakar;Varanya Chaiyaperm
June 23rd 2025
Article

Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

EIT Health Ireland–UK Expands European Network with Three New Members

Patrick Lavery
June 19th 2025
Article

NIBRT, Firefinch, and eg technology will join the center, adding to its collective of healthcare innovators.


Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

BASF Opens GMP Manufacturing Facility in Michigan

Susan Haigney
June 19th 2025
Article

The new facility offers cleanroom packaging and high-sensitivity analytical testing.

Related Content

The mRNA or messenger Ribonucleic Acid white text for medical or outbreak concept 3d rendering | Image Credit: ©niphon - adobe.stock.com

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

Cheryl Barton
June 24th 2025
Article

mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Pharmacist weighing chemical | Image Credit: © Kzenon - stock.adobe.com

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

Paul L. Pluta;Nishant B. Thakar;Varanya Chaiyaperm
June 23rd 2025
Article

Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

EIT Health Ireland–UK Expands European Network with Three New Members

Patrick Lavery
June 19th 2025
Article

NIBRT, Firefinch, and eg technology will join the center, adding to its collective of healthcare innovators.


Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

BASF Opens GMP Manufacturing Facility in Michigan

Susan Haigney
June 19th 2025
Article

The new facility offers cleanroom packaging and high-sensitivity analytical testing.

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.